Transaction DateRecipientSharesTypePriceValue
2nd January 2021Timothy C Crew1,905Payment by withholding$6.52$12,420.60
26th October 2020John Kozlowski658Payment by withholding$6.78$4,461.24
22nd September 2020John Kozlowski87Payment by withholding$6.08$528.96
7th September 2020John Abt10,000Grant/award etc.$0.00
7th September 2020John Kozlowski5,000Grant/award etc.$0.00
3rd September 2020John Abt1,000Open or private sale$5.27$5,270.00
1st September 2020Timothy C Crew3,000Open or private purchase$5.10$15,300.00
1st September 2020Patrick G Lepore38,986Grant/award etc.$0.00
1st September 2020Melissa Rewolinski38,986Grant/award etc.$0.00
1st September 2020Paul Taveira38,986Grant/award etc.$0.00
Lannett Company
Lannett Company logo

Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 4/10.

Lannett Co., Inc. engages in the development, manufacture, marketing, and distribution of generic pharmaceutical products. It offers products in different forms including capsules, tablets, liquids, powders, and sprays. The company was founded in 1942 and is headquartered in Philadelphia, PA.

Ticker: LCI
Sector: Healthcare
Industry: Drug Manufacturers—Specialty & Generic
SEC Central Index Key (CIK): 57725
Employees: 1020
Exchange: New York Stock Exchange
Auditor Opinion:

Disclosure Language changes
Red Flags